Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Associations between fatty acid oxidation, hepatic mitochondrial function, and plasma acylcarnitine levels in mice.

Bjørndal B, Alterås EK, Lindquist C, Svardal A, Skorve J, Berge RK.

Nutr Metab (Lond). 2018 Jan 29;15:10. doi: 10.1186/s12986-018-0241-7. eCollection 2018.

2.

The molecular structure of thio-ether fatty acids influences PPAR-dependent regulation of lipid metabolism.

Lund J, Stensrud C, Rajender, Bohov P, Thoresen GH, Berge RK, Wright M, Kamal A, Rustan AC, Miller AD, Skorve J.

Bioorg Med Chem. 2016 Mar 15;24(6):1191-203. doi: 10.1016/j.bmc.2016.01.045. Epub 2016 Jan 23.

PMID:
26874397
3.

Tetradecylthiopropionic acid induces hepatic mitochondrial dysfunction and steatosis, accompanied by increased plasma homocysteine in mice.

Berge RK, Bjørndal B, Strand E, Bohov P, Lindquist C, Nordrehaug JE, Svardal A, Skorve J, Nygård O.

Lipids Health Dis. 2016 Feb 5;15:24. doi: 10.1186/s12944-016-0192-9.

4.

Fish oil and krill oil differentially modify the liver and brain lipidome when fed to mice.

Skorve J, Hilvo M, Vihervaara T, Burri L, Bohov P, Tillander V, Bjørndal B, Suoniemi M, Laaksonen R, Ekroos K, Berge RK, Alexson SE.

Lipids Health Dis. 2015 Aug 11;14:88. doi: 10.1186/s12944-015-0086-2.

5.

A Protein Extract from Chicken Reduces Plasma Homocysteine in Rats.

Lysne V, Bjørndal B, Vik R, Nordrehaug JE, Skorve J, Nygård O, Berge RK.

Nutrients. 2015 Jun 4;7(6):4498-511. doi: 10.3390/nu7064498.

6.

Three differently generated salmon protein hydrolysates reveal opposite effects on hepatic lipid metabolism in mice fed a high-fat diet.

Vik R, Tillander V, Skorve J, Vihervaara T, Ekroos K, Alexson SE, Berge RK, Bjørndal B.

Food Chem. 2015 Sep 15;183:101-10. doi: 10.1016/j.foodchem.2015.03.011. Epub 2015 Mar 17.

7.

High consumption of farmed salmon does not disrupt the steady state of persistent organic pollutants (POP) in human plasma and adipose tissue.

Hausken T, Skaare JU, Polder A, Haugen M, Meltzer HM, Lundebye AK, Julshamn K, Nygård O, Berge RK, Skorve J.

J Toxicol Environ Health A. 2014;77(20):1229-50. doi: 10.1080/15287394.2014.926262.

PMID:
25208663
8.

A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice.

Parolini C, Vik R, Busnelli M, Bjørndal B, Holm S, Brattelid T, Manzini S, Ganzetti GS, Dellera F, Halvorsen B, Aukrust P, Sirtori CR, Nordrehaug JE, Skorve J, Berge RK, Chiesa G.

PLoS One. 2014 May 19;9(5):e97598. doi: 10.1371/journal.pone.0097598. eCollection 2014.

9.

Fish oil and krill oil supplementations differentially regulate lipid catabolic and synthetic pathways in mice.

Tillander V, Bjørndal B, Burri L, Bohov P, Skorve J, Berge RK, Alexson SE.

Nutr Metab (Lond). 2014 Apr 27;11:20. doi: 10.1186/1743-7075-11-20. eCollection 2014.

10.

Hypolipidemic effect of dietary water-soluble protein extract from chicken: impact on genes regulating hepatic lipid and bile acid metabolism.

Vik R, Bjørndal B, Bohov P, Brattelid T, Svardal A, Nygård OK, Nordrehaug JE, Skorve J, Berge RK.

Eur J Nutr. 2015 Mar;54(2):193-204. doi: 10.1007/s00394-014-0700-5. Epub 2014 Apr 23.

PMID:
24756472
11.

A fish protein hydrolysate alters fatty acid composition in liver and adipose tissue and increases plasma carnitine levels in a mouse model of chronic inflammation.

Bjørndal B, Berge C, Ramsvik MS, Svardal A, Bohov P, Skorve J, Berge RK.

Lipids Health Dis. 2013 Oct 7;12:143. doi: 10.1186/1476-511X-12-143.

12.

Krill powder increases liver lipid catabolism and reduces glucose mobilization in tumor necrosis factor-alpha transgenic mice fed a high-fat diet.

Bjørndal B, Vik R, Brattelid T, Vigerust NF, Burri L, Bohov P, Nygård O, Skorve J, Berge RK.

Metabolism. 2012 Oct;61(10):1461-72. doi: 10.1016/j.metabol.2012.03.012. Epub 2012 Apr 25.

PMID:
22538117
13.

Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents.

Bjørndal B, Burri L, Staalesen V, Skorve J, Berge RK.

J Obes. 2011;2011:490650. doi: 10.1155/2011/490650. Epub 2011 Feb 15.

14.

Anti-inflammatory and hypolipidemic effects of the modified fatty acid tetradecylthioacetic acid in psoriasis--a pilot study.

Morken T, Bohov P, Skorve J, Ulvik R, Aukrust P, Berge RK, Livden JK.

Scand J Clin Lab Invest. 2011 Jul;71(4):269-73. doi: 10.3109/00365513.2011.559552. Epub 2011 Feb 21.

PMID:
21338276
15.

Synthesis of novel PPARα/γ dual agonists as potential drugs for the treatment of the metabolic syndrome and diabetes type II designed using a new de novo design program PROTOBUILD.

Bhurruth-Alcor Y, Røst T, Jorgensen MR, Kontogiorgis C, Skorve J, Cooper RG, Sheridan JM, Hamilton WD, Heal JR, Berge RK, Miller AD.

Org Biomol Chem. 2011 Feb 21;9(4):1169-88. doi: 10.1039/c0ob00146e. Epub 2010 Dec 15.

PMID:
21157612
16.

Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-inflammatory fatty acid index--a pilot study.

Grimstad T, Berge RK, Bohov P, Skorve J, Gøransson L, Omdal R, Aasprong OG, Haugen M, Meltzer HM, Hausken T.

Scand J Clin Lab Invest. 2011 Feb;71(1):68-73. doi: 10.3109/00365513.2010.542484. Epub 2010 Dec 8.

PMID:
21142420
17.

Novel phospholipid analogues of pan-PPAR activator tetradecylthioacetic acid are more PPAR alpha selective.

Bhurruth-Alcor Y, Rost TH, Jorgensen MR, Rajender, Müller M, Skorve J, Berge RK, Miller AD.

Bioorg Med Chem Lett. 2010 Feb 1;20(3):1252-5. doi: 10.1016/j.bmcl.2009.11.115. Epub 2009 Dec 11.

PMID:
20036122
18.

Trans-10, cis-12-conjugated linoleic acid reduces the hepatic triacylglycerol content and the leptin mRNA level in adipose tissue in obese Zucker fa/fa rats.

Gudbrandsen OA, Rodríguez E, Wergedahl H, Mørk S, Reseland JE, Skorve J, Palou A, Berge RK.

Br J Nutr. 2009 Sep;102(6):803-15. doi: 10.1017/S0007114509297200. Epub 2009 Mar 19.

PMID:
19298684
19.

Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation.

Løvås K, Røst TH, Skorve J, Ulvik RJ, Gudbrandsen OA, Bohov P, Wensaas AJ, Rustan AC, Berge RK, Husebye ES.

Diabetes Obes Metab. 2009 Apr;11(4):304-14. doi: 10.1111/j.1463-1326.2008.00958.x.

PMID:
19267708
20.

Synthesis and analysis of novel glycerolipids for the treatment of metabolic syndrome.

Jorgensen MR, Bhurruth-Alcor Y, Røst T, Bohov P, Müller M, Guisado C, Kostarelos K, Dyrøy E, Berge RK, Miller AD, Skorve J.

J Med Chem. 2009 Feb 26;52(4):1172-9. doi: 10.1021/jm801019s.

PMID:
19175322

Supplemental Content

Loading ...
Support Center